Sur cette page
CRDF Cardiff Oncology, Inc. - Common Stock
NASDAQ · Biotechnology · Voir sur SEC EDGAR ↗ clôture Oct 2, 2026 10-K/10-Q Aoû 11, 2026
$1,12
· % de la fourchette 52 sem.
· au-dessus du plus bas
· vers le haut
$0,76Bas 52 semaines
$3,31Haut 52 semaines
Capitalisation Boursière (MRQ)
$77M
P/E (TTM)
-1.9
BPA (TTM)
$-0.60
Revenu (TTM)
$508.0K
vos badges
Fourchette 52 semaines
$1–$3
Note des analystes
BUY
Objectif de cours
$6
P/E
-1.9
ROE
-94.1%
Marge nette
-7884.1%
Votre barre de badges est vide — épinglez une métrique n'importe où sur cette page.
CRDF Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$1.12
Capitalisation Boursière (MRQ)
$77M
P/E (TTM)
-1.9
BPA (TTM)
$-0.60
Revenu (TTM)
$508.0K
ROE (TTM)
-94.1%
Fourchette 52 semaines
$1–$3
CRDF Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
fourchette
barres
La granularité des barres s'adapte à la période sélectionnée — survolez le graphique pour voir l'ouverture/le maximum/le minimum/la clôture d'une barre.
Splits d'actions
| Date ex-dividende | Division | Type |
|---|---|---|
| 20 février 2019 | 1-for-6 | Inverse |
| 4 juin 2018 | 1-for-12 | Inverse |
| 30 mai 2012 | 1-for-6 | Inverse |
| 27 juillet 2004 | 111-for-1 | Avant |
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenu$593.0K2016-12-31 → 2025-12-31
BPA$-0.692016-12-31 → 2025-12-31
Flux de trésorerie libre$-38M2016-12-31 → 2025-12-31
Marge nette-7884.1%2016-12-31 → 2025-12-31
Valorisation et Ratios
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
| Métrique | Tendance sur 5 ans | CRDF | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -1.9moyenne 5 ans ≈-4.0 | ≈-4.0 | · | · | |
| P/S (TTM) | 151.0moyenne 5 ans ≈349.3 | ≈349.3 | 70.6 | Surévalué | |
| P/B (MRQ) | 2.9moyenne 5 ans ≈2.2 | ≈2.2 | 2.3 | Surévalué | |
| Price / FCF (Cours / FCF) | -2.0moyenne 5 ans ≈-5.5 | ≈-5.5 | · | · | |
| Price / Cash Flow (Cours / Flux de trésorerie) | -2.0moyenne 5 ans ≈-5.5 | ≈-5.5 | · | · | |
| Price / Tangible Book (Cours / Actif net tangible) | 1.7moyenne 5 ans ≈2.2 | ≈2.2 | · | · |
La médiane des pairs est calculée sur une base standardisée par métrique et peut ne pas toujours correspondre à la base TTM/MRQ indiquée pour cette action.
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
| Métrique | Tendance sur 5 ans | CRDF | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Marge d'exploitation (TTM) | -8320.1%moyenne 5 ans ≈-8612.0% | ≈-8612.0% | -749.2% | Faible | |
| Marge EBITDA (TTM) | -8251.0%moyenne 5 ans ≈-8534.2% | ≈-8534.2% | -749.2% | Faible | |
| Pretax Margin (Marge avant impôts) | -7732.0% | · | -1847.2% | Faible | |
| Marge nette (TTM) | -7884.1%moyenne 5 ans ≈-8156.6% | ≈-8156.6% | -767.3% | Faible | |
| ROA (TTM) | -70.8%moyenne 5 ans ≈-39.9% | ≈-39.9% | -26.7% | Faible | |
| ROE (TTM) | -94.1%moyenne 5 ans ≈-53.8% | ≈-53.8% | -61.5% | Faible | |
| ROIC | -107.9% | · | -55.9% | Faible |
Santé financière Dette, liquidité, solvabilité — solidité du bilan
| Métrique | Tendance sur 5 ans | CRDF | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Ratio de liquidité (MRQ) | 3.3moyenne 5 ans ≈10.9 | ≈10.9 | 5.0 | Faible liquidité | |
| Ratio de liquidité réduite (MRQ) | 3.2moyenne 5 ans ≈10.6 | ≈10.6 | 3.3 | En ligne |
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
| Métrique | Tendance sur 5 ans | CRDF | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Revenue YoY (Chiffre d'affaires YoY) | -13.2%moyenne 5 ans ≈11.8% | ≈11.8% | · | · | |
| Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans) | 15.4%moyenne 5 ans ≈16.5% | ≈16.5% | · | · | |
| Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans) | 10.1% | · | · | · |
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
| Métrique | Tendance sur 5 ans | CRDF | moyenne 5 ans | Médiane des pairs | Verdict |
|---|---|---|---|---|---|
| Asset Turnover (Rotation des actifs) | 0.0moyenne 5 ans ≈0.0 | ≈0.0 | 0.0 | Faible | |
| Receivables Turnover (Rotation des créances) | 1.2moyenne 5 ans ≈1.0 | ≈1.0 | · | · | |
| Revenue / Employee (Chiffre d'affaires annuel ÷ employés (effectif déclaré, yfinance). Dérivé — pas un concept SEC-XBRL stocké.) | ≈$19.8K | · | · | · |
valeur · ≈ moyenne 5 ans · médiane du secteur · verdict par rapport à la médiane
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
5.5%
Prochain rapport
Nov 04, 2026
| Période | Rapport | EPS Actual | BPA est. | Surprise |
|---|---|---|---|---|
| 30 juin 2026 | Jul 27, 2026 | $-0.14 | $-0.16 | 14.9% |
| 31 mars 2026 | Mai 14, 2026 | $-0.18 | $-0.14 | -31.1% |
| 31 décembre 2025 | $-0.11 | $-0.19 | 42.6% | |
| 30 septembre 2025 | $-0.17 | $-0.21 | 18.5% | |
| 30 juin 2025 | $-0.21 | $-0.20 | -6.9% | |
| 31 mars 2025 | $-0.20 | $-0.19 | -5.3% |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $593.0K | $683.0K | $488.0K | $386.0K | $359.0K | $366.0K | $244.6K | $378.3K | $505.4K | $381.1K | $312.8K | $280.2K | |
| Cost of Revenue | · | · | · | · | · | · | $0 | $597.5K | $2M | $2M | $629.2K | $15.4K | |
| R&D Expense | · | · | · | $27M | $17M | $11M | · | · | · | · | · | · | |
| SG&A Expense | $14M | $12M | $13M | $13M | $12M | $8M | $6M | $8M | $14M | $11M | $8M | $6M | |
| Operating Expenses | $50M | $49M | $46M | $40M | $29M | $19M | $17M | $17M | $26M | $41M | $26M | $15M | |
| Operating Income | $-49M | $-49M | $-45M | $-40M | $-29M | $-19M | $-17M | $-17M | $-26M | $-40M | $-25M | $-15M | |
| Interest Expense | · | · | · | · | $0 | $2.0K | $0 | $25.4K | $1M | $2M | $2M | $843.3K | |
| Interest Income | $3M | $3M | $4M | $2M | $264.0K | $90.0K | $234.2K | $219.4K | $147.9K | $298.8K | · | · | |
| Other Non-op | $5.0K | $-39.0K | $-98.0K | $1M | $564.0K | $-221.0K | · | · | · | · | · | · | |
| Pretax Income | $-46M | $-45M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-46M | $-45M | $-41M | $-39M | $-28M | $-19M | $-16M | $-16M | $-25M | $-39M | $-27M | $-14M | |
| EPS (Basic) | $-0.69 | $-0.95 | $-0.93 | $-0.89 | $-0.73 | $-1.08 | · | $-8.26 | $-51.76 | $-1.30 | $-1.05 | $-0.76 | |
| EPS (Diluted) | $-0.69 | $-0.95 | $-0.93 | $-0.89 | $-0.73 | $-1.08 | · | $-8.26 | $-51.76 | $-1.37 | $-1.21 | $-0.88 | |
| Shares (Basic) | 66,841,000 | 47,650,000 | 44,677,000 | 43,600,000 | 39,030,000 | 20,875,000 | 5,973,906 | 2,330,180 | 481,672 | 30,174,838 | 26,201,713 | 18,904,280 | |
| Shares (Diluted) | 66,841,000 | 47,650,000 | 44,677,000 | 43,600,000 | 39,030,000 | 20,875,000 | · | 2,330,180 | 481,672 | 30,281,263 | 26,452,165 | 19,071,112 | |
| EBITDA | $-49M | $-48M | $-45M | $-40M | $-28M | $-19M | $-16M | $-16M | $-24M | $-39M | $-25M | $-15M |
Bilan
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17M | $51M | $22M | $16M | $12M | $131M | $10M | $11M | $8M | $14M | $67M | $67M | |
| Short-term Investments | $41M | $40M | $53M | $89M | $129M | $0 | · | · | $0 | $24M | $0 | · | |
| Receivables | $182.0K | $773.0K | $288.0K | $771.0K | $535.0K | $320.0K | $203.5K | $167.8K | $77.1K | $100.5K | $98.7K | $56.7K | |
| Prepaid Expense | $2M | $3M | $2M | $5M | $5M | $2M | $955.0K | $1M | $1M | $956.6K | $789.3K | $369.3K | |
| Current Assets | $60M | $95M | $77M | $111M | $146M | $133M | $11M | $13M | $9M | $39M | $68M | $28M | |
| PP&E (Net) | $578.0K | $898.0K | $1M | $1M | $382.0K | $624.0K | $877.8K | $1M | $2M | $4M | $3M | $840.4K | |
| PP&E (Gross) | $5M | $5M | $5M | $5M | $4M | $4M | $3M | $3M | $4M | $6M | $4M | $1M | |
| Accum. Depreciation | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $854.8K | $533.9K | |
| Other Non-current Assets | $549.0K | $69.0K | $1M | $1M | $239.0K | $404.0K | $157.6K | $102.8K | $389.9K | $1M | $374.0K | $336.7K | |
| Total Assets | $62M | $97M | $82M | $116M | $150M | $135M | $13M | $14M | $12M | $44M | $71M | $29M | |
| Accounts Payable | $8M | $5M | $2M | $2M | $1M | $1M | $656.3K | $664.8K | $825.2K | $1M | $1M | $747.8K | |
| Accrued Liabilities | $8M | $8M | $8M | $5M | $5M | $4M | $3M | $2M | $1M | $4M | $2M | $2M | |
| Short-term Debt | · | · | · | · | · | · | $0 | · | · | · | · | · | |
| Current Liabilities | $16M | $13M | $10M | $8M | $7M | $6M | $5M | $3M | $4M | $8M | $8M | $4M | |
| Capital Leases | $102.0K | $813.0K | $1M | $2M | $3M | $9.0K | $861.0K | $0 | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $0 | $156.0K | $128.4K | $42.0K | · | · | $0 | · | |
| Total Liabilities | $16M | $14M | $12M | $10M | $9M | $7M | $6M | $4M | $6M | $24M | $23M | $21M | |
| Common Stock | $7.0K | $7.0K | $4.0K | $4.0K | $4.0K | $4.0K | $8.3K | $7.7K | $5.3K | $3.1K | $3.0K | $1.9K | |
| Paid-in Capital | $475M | $467M | $409M | $405M | $401M | $362M | $217M | $202M | $180M | $168M | $158M | $90M | |
| Retained Earnings | $-430M | $-384M | $-340M | $-298M | $-260M | $-231M | $-209M | $-192M | $-173M | $-148M | $-109M | $-81M | |
| AOCI | $50.0K | $34.0K | $-67.0K | $-395.0K | $-142.0K | $0 | · | · | $0 | $-10.8K | $0 | · | |
| Stockholders' Equity | $45M | $83M | $70M | $106M | $140M | $128M | $7M | $10M | $7M | $20M | $49M | $8M | |
| Liabilities + Equity | $62M | $97M | $82M | $116M | $150M | $135M | $13M | $14M | $12M | $44M | $71M | $29M | |
| Shares Outstanding | 68,305,000 | 66,524,000 | 44,677,000 | 44,677,000 | 41,964,000 | 36,781,000 | 8,593,633 | 3,831,879 | 733,217 | 30,696,791 | 29,737,601 | 18,915,793 |
Flux de trésorerie
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $364.0K | $404.0K | $398.0K | $236.0K | $451.0K | $466.0K | $494.2K | $859.5K | $1M | $1M | $378.7K | $234.8K | |
| Stock-based Comp | $6M | $5M | $5M | $4M | $3M | $2M | $884.9K | $2M | $4M | $8M | $4M | $2M | |
| Deferred Tax | $-9M | $-9M | $-9M | $24M | $-6M | $-4M | $-3M | $-4M | $13M | $-17M | $-11M | $-6M | |
| Restructuring | · | · | · | · | · | · | $0 | $664.7K | $2M | $790.4K | $0 | $0 | |
| Other Non-cash | $11M | $12M | $15M | $-24M | $8M | $5M | $5M | $4M | $-17M | $16M | $12M | $-706.9K | |
| Operating Cash Flow | $-38M | $-38M | $-31M | $-34M | $-23M | $-16M | $-13M | $-13M | $-23M | $-31M | $-22M | $-13M | |
| CapEx | $44.0K | $80.0K | $582.0K | $1M | $205.0K | $211.0K | $67.6K | $5.1K | $101.1K | $823.5K | $2M | $363.3K | |
| Investing Cash Flow | $1M | $14M | $36M | $38M | $-131M | $-211.0K | $-67.6K | $22.8K | · | · | · | · | |
| Debt Issued | · | · | · | · | $0 | $305.0K | $0 | · | $0 | $8M | $0 | $15M | |
| Net Debt Issued | · | · | · | · | $0 | $305.0K | · | $0 | $-15M | $-1M | $0 | $15M | |
| Stock Issued | $0 | $53M | · | $0 | $34M | $112M | $9M | $12M | $12M | $2M | $61M | $0 | |
| Net Stock Activity | $0 | $53M | · | $0 | $34M | $112M | $9M | $13M | $12M | $2M | $61M | · | |
| Financing Cash Flow | $3M | $54M | $0 | $75.0K | $35M | $137M | $12M | $16M | · | · | · | · | |
| Net Change in Cash | $-34M | $30M | $5M | $4M | $-119M | $121M | $-1M | $3M | · | · | · | · | |
| Taxes Paid | $1.0K | $1.0K | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-38M | $-38M | $-31M | $-35M | $-23M | $-17M | $-13M | $-13M | $-23M | $-32M | $-24M | $-13M |
Rentabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -8256.3% | -7123.1% | -9305.7% | -10337.3% | -8037.6% | -5214.8% | -6817.8% | -4507.6% | -5064.4% | -10534.9% | -8079.5% | -5334.2% | |
| Net Margin | -7732.0% | -6651.7% | -8492.0% | -10026.9% | -7880.5% | -5275.1% | -6709.7% | -4351.1% | -4928.1% | -10287.8% | -8782.0% | -5113.0% | |
| Pretax Margin | -7732.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -8194.9% | -7064.0% | -9224.2% | -10276.2% | -7912.0% | -5087.5% | -6615.8% | -4280.4% | -4817.6% | -10254.2% | -7958.4% | -5250.4% | |
| ROA | -57.6% | -50.8% | -41.9% | -29.1% | -19.9% | -26.1% | -120.4% | -124.4% | -88.6% | -68.0% | -54.8% | -51.1% | |
| ROE | -88.2% | -68.7% | -56.2% | -35.3% | -20.6% | -23.9% | -235.0% | -136.8% | -189.6% | -114.5% | -96.3% | -99.7% | |
| ROIC | -107.9% | · | · | · | · | · | · | · | · | · | · | · |
Liquidité et Solvabilité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.7 | 7.1 | 7.4 | 14.3 | 22.3 | 21.8 | 2.4 | 4.3 | 2.4 | 5.0 | 8.3 | 6.2 | |
| Quick Ratio | 3.6 | 6.9 | 7.2 | 13.6 | 21.6 | 21.5 | 2.2 | 3.9 | 2.1 | 4.9 | 8.2 | 6.1 | |
| Interest Coverage | · | · | · | · | · | -12564.8 | · | -671.2 | -24.8 | · | -16.6 | -17.7 |
Efficacité
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | 1.2 | 1.3 | 0.9 | 0.6 | 0.8 | 1.4 | 1.3 | 3.1 | 5.7 | 3.8 | 4.0 | 4.1 |
Par action
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.66 | $1.25 | $1.56 | $2.38 | $3.35 | $3.48 | $0.85 | $2.63 | $0.12 | $0.64 | $1.64 | $0.44 | |
| Revenue / Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | · | · | $0.16 | $0.01 | $0.01 | $0.01 | $0.01 | |
| Cash Flow / Share | $-0.57 | $-0.79 | $-0.69 | $-0.78 | $-0.59 | · | · | $-5.66 | $-0.67 | $-1.03 | $-0.84 | $-0.67 | |
| Cash / Share | $0.26 | $0.77 | $0.48 | $0.37 | $0.28 | $3.56 | $1.19 | $2.99 | $0.16 | $0.45 | $2.27 | $1.44 | |
| EPS (TTM) | $-0.69 | $-0.95 | $-0.93 | $-0.89 | $-0.73 | $-1.08 | $-3.62 | $-8.26 | $-51.76 | $-1.37 | $-1.21 | $-0.88 |
Taux de croissance
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -13.2% | 40.0% | 26.4% | 7.5% | -1.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 15.4% | 23.9% | 10.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.1% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM)
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $593.0K | $683.0K | $488.0K | $386.0K | $359.0K | $366.0K | $244.6K | $378.3K | $505.4K | $381.1K | $312.8K | $280.2K | |
| Net Income TTM | $-46M | $-45M | $-41M | $-39M | $-28M | $-19M | $-16M | $-16M | $-25M | $-39M | $-27M | $-14M | |
| Market Cap | $192M | $289M | $66M | $63M | $252M | $662M | $11M | $12M | $1.18B | $4.64B | $11.56B | $5.86B | |
| P/E | -4.1 | -4.6 | -1.6 | -1.6 | -8.2 | -16.7 | -0.3 | -0.4 | -0.4 | -110.4 | -321.3 | -351.8 | |
| P/S | 323.7 | 422.7 | 135.5 | 162.0 | 702.5 | 1807.9 | 43.6 | 32.2 | 2331.4 | 12179.7 | 36961.4 | 20902.2 | |
| P/B | 4.2 | 3.5 | 0.9 | 0.6 | 1.8 | 5.2 | 1.5 | 1.2 | 181.1 | 234.8 | 237.4 | 701.4 | |
| P / Tangible Book | 4.2 | 3.5 | 0.9 | 0.6 | 1.8 | 5.2 | · | · | · | · | · | · | |
| P / Cash Flow | -5.1 | -7.7 | -2.1 | -1.8 | -10.9 | -40.6 | -0.8 | -0.9 | -50.6 | -149.5 | -522.7 | -460.1 | |
| P / FCF | -5.1 | -7.6 | -2.1 | -1.8 | -10.8 | -40.0 | -0.8 | -0.9 | -50.4 | -145.7 | -474.6 | -447.4 | |
| Earnings Yield | -24.6% | -21.9% | -62.8% | -63.6% | -12.2% | -6.0% | -291.9% | -259.8% | -231.9% | -0.91% | -0.31% | -0.28% |
Compte de résultat
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $104.0K | $41.0K | $243.0K | $120.0K | $121.0K | $109.0K | $150.0K | $165.0K | $163.0K | $205.0K | $156.0K | $141.0K | $108.0K | $83.0K | $128.0K | $93.0K | |
| SG&A Expense | $4M | $6M | $3M | $4M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | |
| Operating Expenses | $10M | $13M | $8M | $12M | $15M | $14M | $13M | $13M | $13M | $11M | $10M | $11M | $12M | $12M | $10M | $9M | |
| Operating Income | $-10M | $-13M | $-8M | $-12M | $-15M | $-14M | $-13M | $-13M | $-13M | $-11M | $-10M | $-11M | $-12M | $-12M | $-9M | $-9M | |
| Interest Income | $382.0K | $506.0K | $612.0K | $716.0K | $835.0K | $941.0K | $787.0K | $741.0K | $805.0K | $926.0K | $1M | $1M | $1M | $940.0K | $740.0K | $458.0K | |
| Other Non-op | $1.0K | $-1.0K | $-1.0K | $0 | $-1.0K | $7.0K | $-2.0K | $5.0K | $-38.0K | $-4.0K | $-13.0K | $21.0K | $5.0K | $-111.0K | $2M | $-36.0K | |
| Net Income | $-9M | $-12M | $-7M | $-11M | $-14M | $-13M | $-12M | $-12M | $-12M | $-10M | $-9M | $-10M | $-11M | $-11M | $-9M | $-9M | |
| EPS (Basic) | $-0.14 | $-0.18 | $-0.11 | $-0.17 | $-0.21 | $-0.20 | $-0.22 | $-0.25 | $-0.26 | $-0.22 | $-0.21 | $-0.22 | $-0.25 | $-0.25 | $-0.20 | $-0.20 | |
| EPS (Diluted) | $-0.14 | $-0.18 | $-0.11 | $-0.17 | $-0.21 | $-0.20 | $-0.22 | $-0.25 | $-0.26 | $-0.22 | $-0.21 | $-0.22 | $-0.25 | $-0.25 | $-0.20 | $-0.20 | |
| Shares (Basic) | 68,397,000 | 68,350,000 | · | 66,879,000 | 66,526,000 | 66,524,000 | · | 46,865,000 | 44,825,000 | 44,678,000 | · | 44,677,000 | 44,677,000 | 44,677,000 | · | 43,333,000 | |
| Shares (Diluted) | 68,397,000 | 68,350,000 | · | 66,879,000 | 66,526,000 | 66,524,000 | · | 46,865,000 | 44,825,000 | 44,678,000 | · | 44,677,000 | 44,677,000 | 44,677,000 | · | 43,333,000 | |
| EBITDA | $-10M | $-13M | · | · | $-15M | $-14M | · | $-13M | $-13M | $-11M | · | $-11M | $-12M | $-12M | · | · |
Bilan
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $9M | $17M | $10M | $11M | $24M | $51M | $13M | $26M | $19M | $22M | $15M | $19M | $15M | $16M | $19M | |
| Short-term Investments | $25M | $38M | $41M | $50M | $60M | $56M | $40M | $45M | $35M | $49M | $53M | $66M | $70M | $82M | $89M | $96M | |
| Receivables | $189.0K | $191.0K | $182.0K | $254.0K | $526.0K | $405.0K | $773.0K | $618.0K | $451.0K | $393.0K | $288.0K | $198.0K | $161.0K | $676.0K | $771.0K | $650.0K | |
| Prepaid Expense | $883.0K | $1M | $2M | $956.0K | $2M | $2M | $3M | $1M | $1M | $2M | $2M | $2M | $3M | $4M | $5M | $5M | |
| Current Assets | $36M | $47M | $60M | $62M | $74M | $83M | $95M | $59M | $62M | $70M | $77M | $84M | $93M | $102M | $111M | $120M | |
| PP&E (Net) | $450.0K | $491.0K | $578.0K | $666.0K | $743.0K | $805.0K | $898.0K | $993.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | $5M | $5M | $5M | · | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | $4M | $5M | $4M | · | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Other Non-current Assets | $927.0K | $844.0K | $549.0K | $549.0K | $401.0K | $257.0K | $69.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $184.0K | |
| Total Assets | $37M | $49M | $62M | $64M | $76M | $85M | $97M | $63M | $66M | $74M | $82M | $88M | $97M | $107M | $116M | $124M | |
| Accounts Payable | $4M | $5M | $8M | $2M | $6M | $4M | $5M | $5M | $5M | $5M | $2M | $2M | $3M | $3M | $2M | $1M | |
| Accrued Liabilities | $6M | $8M | $8M | $12M | $10M | $9M | $8M | $7M | $7M | $6M | $8M | $6M | $6M | $5M | $5M | $6M | |
| Current Liabilities | $11M | $14M | $16M | $15M | $17M | $13M | $13M | $13M | $13M | $12M | $10M | $9M | $9M | $8M | $8M | $8M | |
| Capital Leases | $0 | $0 | $102.0K | $284.0K | $464.0K | $640.0K | $813.0K | $979.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | |
| Total Liabilities | $11M | $14M | $16M | $15M | $17M | $14M | $14M | $14M | $14M | $13M | $12M | $11M | $11M | $10M | $10M | $10M | |
| Common Stock | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $478M | $477M | $475M | $472M | $470M | $468M | $467M | $422M | $413M | $410M | $409M | $408M | $407M | $406M | $405M | $404M | |
| Retained Earnings | $-452M | $-442M | $-430M | $-423M | $-412M | $-398M | $-384M | $-372M | $-361M | $-349M | $-340M | $-330M | $-320M | $-309M | $-298M | $-290M | |
| AOCI | $-62.0K | $-49.0K | $50.0K | $50.0K | $17.0K | $27.0K | $34.0K | $82.0K | $-97.0K | $-132.0K | $-67.0K | $-407.0K | $-431.0K | $-76.0K | $-395.0K | $-779.0K | |
| Stockholders' Equity | $27M | $35M | $45M | $49M | $59M | $71M | $83M | $49M | $52M | $61M | $70M | $78M | $87M | $97M | $106M | $113M | |
| Liabilities + Equity | $37M | $49M | $62M | $64M | $76M | $85M | $97M | $63M | $66M | $74M | $82M | $88M | $97M | $107M | $116M | $124M | |
| Shares Outstanding | 68,502,000 | 68,370,000 | 68,305,000 | 67,095,000 | 66,526,000 | 66,526,000 | 66,524,000 | 48,731,000 | 45,602,000 | 44,710,000 | 44,677,000 | 44,677,000 | 44,677,000 | 44,677,000 | 44,677,000 | 43,335,000 |
Flux de trésorerie
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $87.0K | $87.0K | $88.0K | $89.0K | $94.0K | $93.0K | $96.0K | $101.0K | $105.0K | $102.0K | $103.0K | $107.0K | $98.0K | $90.0K | $86.0K | $81.0K | |
| Stock-based Comp | $920.0K | $2M | $1M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $909.0K | $955.0K | $2M | $1M | $1M | $1M | |
| Other Non-cash | · | $-2M | · | · | · | $-818.0K | · | · | · | $1M | · | · | · | $1M | · | · | |
| Operating Cash Flow | $-12M | $-12M | $-6M | $-11M | $-8M | $-13M | $-10M | $-10M | $-9M | $-8M | $-7M | $-8M | $-7M | $-9M | $-9M | $-7M | |
| CapEx | · | · | $0 | $18.0K | · | · | $0 | $0 | $0 | $80.0K | $8.0K | $315.0K | $251.0K | $8.0K | $75.0K | $448.0K | |
| Investing Cash Flow | $12M | $3M | $11M | $10M | $-5M | $-15M | $5M | $-9M | $14M | $5M | $14M | $4M | $11M | $7M | $7M | $5M | |
| Stock Issued | · | · | · | · | · | · | $44M | $7M | · | · | · | · | · | · | · | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | $7M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $149.0K | $105.0K | $3M | $25.0K | $0 | $3.0K | $44M | $7M | $2M | $107.0K | · | $0 | $0 | $0 | $0 | $75.0K | |
| Net Change in Cash | $653.0K | $-9M | $7M | $-649.0K | $-13M | $-27M | $38M | $-12M | $7M | $-3M | $6M | $-4M | $4M | $-1M | $-2M | $-2M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-8M | · | · | · | $-9M | · | · |
Rentabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -9245.2% | -31341.5% | · | -9978.3% | -12212.4% | -13194.5% | · | -7637.0% | -7696.3% | -5333.2% | · | -7673.8% | -11303.7% | -14520.5% | · | · | |
| Net Margin | -8876.9% | -30109.8% | · | · | -11523.1% | -12324.8% | · | -7184.9% | -7225.8% | -4883.4% | · | -6901.4% | -10324.1% | -13521.7% | · | · | |
| EBITDA Margin | -9245.2% | -31129.3% | · | · | -12212.4% | -13109.2% | · | -7637.0% | -7696.3% | -5283.4% | · | -7673.8% | -11303.7% | -14412.0% | · | · | |
| ROA | -16.3% | -18.4% | · | · | -19.7% | -16.9% | · | -15.7% | -14.4% | -11.1% | · | -9.2% | -9.8% | -9.1% | · | · | |
| ROE | -21.7% | -23.4% | · | · | -25.1% | -20.4% | · | -18.6% | -17.0% | -12.7% | · | -10.2% | -10.8% | -9.9% | · | · |
Liquidité et Solvabilité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 3.3 | · | · | 4.4 | 6.2 | · | 4.7 | 5.0 | 5.9 | · | 9.3 | 10.2 | 12.5 | · | · | |
| Quick Ratio | 3.2 | 3.2 | · | · | 4.3 | 6.0 | · | 4.7 | 4.9 | 5.7 | · | 9.0 | 9.8 | 12.0 | · | · |
Efficacité
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Receivables Turnover | 0.3 | 0.1 | · | · | 0.2 | 0.3 | · | 0.4 | 0.5 | 0.4 | · | 0.3 | 0.3 | 0.1 | · | · |
Par action
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.39 | $0.51 | · | · | $0.88 | $1.07 | · | $1.01 | $1.15 | $1.36 | · | $1.74 | $1.94 | $2.16 | · | · | |
| Revenue / Share | $0.00 | $0.00 | · | · | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | · | |
| Cash Flow / Share | · | $-0.18 | · | · | · | $-0.19 | · | · | · | $-0.17 | · | · | · | $-0.19 | · | · | |
| Cash / Share | $0.13 | $0.12 | · | · | $0.16 | $0.36 | · | $0.27 | $0.56 | $0.42 | · | $0.34 | $0.43 | $0.34 | · | · | |
| EPS (TTM) | $-0.60 | $-0.67 | · | $-0.80 | $-0.88 | $-0.93 | · | $-0.94 | $-0.91 | $-0.90 | · | $-0.92 | $-0.90 | $-0.89 | · | $-0.94 |
Valorisation (TTM)
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $508.0K | $525.0K | · | $500.0K | $545.0K | $587.0K | · | $689.0K | $665.0K | $610.0K | · | $460.0K | $412.0K | $395.0K | · | $391.0K | |
| Net Income TTM | $-40M | $-45M | · | $-50M | $-51M | $-49M | · | $-43M | $-41M | $-40M | · | $-41M | $-40M | $-39M | · | $-39M | |
| Market Cap | $89M | $111M | · | · | $210M | $209M | · | $130M | $101M | $239M | · | $62M | $66M | $74M | · | · | |
| P/E | -2.2 | -2.4 | · | -2.6 | -3.6 | -3.4 | · | -2.8 | -2.4 | -5.9 | · | -1.5 | -1.6 | -1.9 | · | -1.6 | |
| P/S | 175.3 | 211.0 | · | · | 384.5 | 355.9 | · | 188.8 | 152.2 | 391.4 | · | 135.0 | 159.4 | 186.6 | · | · | |
| P/B | 3.4 | 3.2 | · | · | 3.6 | 2.9 | · | 2.6 | 1.9 | 3.9 | · | 0.8 | 0.8 | 0.8 | · | · | |
| P / Tangible Book | 3.4 | 3.2 | · | 2.8 | 3.6 | 2.9 | · | 2.6 | 1.9 | 3.9 | · | 0.8 | 0.8 | 0.8 | · | 0.6 | |
| P / Cash Flow | · | -9.0 | · | · | · | -16.3 | · | · | · | -30.8 | · | · | · | -8.5 | · | · | |
| Earnings Yield | -46.2% | -41.4% | · | -38.8% | -27.9% | -29.6% | · | -35.2% | -41.0% | -16.9% | · | -66.2% | -61.2% | -53.9% | · | -61.0% |
Période la plus récente à gauche · valeurs nulles affichées comme ·
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenu | $593.0K | $683.0K | $488.0K | $386.0K | $359.0K |
| Marge d'exploitation % | -8256.3% | -7123.1% | -9305.7% | -10337.3% | -8037.6% |
| Résultat net | $-46M | $-45M | $-41M | $-39M | $-28M |
| BPA dilué | $-0.69 | $-0.95 | $-0.93 | $-0.89 | $-0.73 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio de liquidité | 3.7 | 7.1 | 7.4 | 14.3 | 22.3 |
| Ratio de liquidité réduite | 3.6 | 6.9 | 7.2 | 13.6 | 21.6 |
| Métrique | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-38M | $-38M | $-31M | $-35M | $-23M |
Détenteurs institutionnels (13F) 119 déclarants · $36.6M total · Au 30 septembre 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Détenteurs
119
Valeur détenue
$36.6M
Nouvelles positions
21
Positions clôturées
29
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 21 (-3 vs T. préc.) | 29 (+16 vs T. préc.) | 34 (+2 vs T. préc.) | 28 (-9 vs T. préc.) | -6.3M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $10 459 059 | 3 722 085 | 28,57% | Actions |
| Laurion Capital Management LP | $4 027 789 | 3 098 299 | 11,00% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $3 764 270 | 2 895 592 | 10,28% | Actions |
| Pfizer Inc | $3 014 469 | 2 411 575 | 8,23% | Actions |
| FRANKLIN RESOURCES INC | $1 567 544 | 1 205 803 | 4,28% | Actions |
| BlackRock, Inc. | $1 264 735 | 972 873 | 3,45% | Actions |
| BLAIR WILLIAM & CO/IL | $1 186 267 | 912 513 | 3,24% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $1 066 639 | 820 062 | 2,91% | Actions |
| TWO SIGMA ADVISERS, LP | $1 013 005 | 360 500 | 2,77% | Actions |
| GoalVest Advisory LLC | $831 615 | 687 285 | 2,27% | Actions |
| UBS Group AG | $830 309 | 638 699 | 2,27% | Actions |
| JANE STREET GROUP, LLC | $790 270 | 607 900 | 2,16% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $533 783 | 410 602 | 1,46% | Actions |
| AQR CAPITAL MANAGEMENT LLC | $450 260 | 346 353 | 1,23% | Actions |
| STATE STREET CORP | $430 814 | 331 395 | 1,18% | Actions |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $321 716 | 247 474 | 0,88% | Actions |
| MORGAN STANLEY | $319 924 | 246 095 | 0,87% | Actions |
| Callan Capital, LLC | $318 946 | 101 575 | 0,87% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $296 999 | 228 461 | 0,81% | Actions |
| CITADEL ADVISORS LLC | $239 720 | 184 400 | 0,65% | Option d'achat |
| MARSHALL WACE, LLP | $210 879 | 162 214 | 0,58% | Actions |
| Bank of New York Mellon Corp | $210 196 | 161 689 | 0,57% | Actions |
| NORTHERN TRUST CORP | $198 738 | 152 875 | 0,54% | Actions |
| Cubist Systematic Strategies, LLC | $183 140 | 88 903 | 0,50% | Actions |
| Avestar Capital, LLC | $176 989 | 136 145 | 0,48% | Actions |
| MILLENNIUM MANAGEMENT LLC | $174 872 | 134 517 | 0,48% | Actions |
| Qube Research & Technologies Ltd | $163 215 | 125 550 | 0,45% | Actions |
| GOLDMAN SACHS GROUP INC | $157 076 | 120 827 | 0,43% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $150 979 | 116 138 | 0,41% | Actions |
| AlphaCore Capital LLC | $141 041 | 108 493 | 0,39% | Actions |
| XTX Topco Ltd | $126 620 | 97 400 | 0,35% | Actions |
| Squarepoint Ops LLC | $124 917 | 96 090 | 0,34% | Actions |
| JANE STREET GROUP, LLC | $105 300 | 81 000 | 0,29% | Option d'achat |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $93 674 | 72 057 | 0,26% | Actions |
| Assenagon Asset Management S.A. | $87 400 | 67 231 | 0,24% | Actions |
| WOLVERINE TRADING, LLC | $84 448 | 40 600 | 0,23% | Option d'achat |
| CAPSTONE INVESTMENT ADVISORS, LLC | $66 547 | 51 190 | 0,18% | Actions |
| Mariner, LLC | $64 163 | 49 356 | 0,18% | Actions |
| Creative Planning | $62 526 | 48 097 | 0,17% | Actions |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | $62 400 | 48 000 | 0,17% | Actions |
| TWO SIGMA INVESTMENTS, LP | $61 966 | 47 666 | 0,17% | Actions |
| IEQ CAPITAL, LLC | $58 019 | 44 630 | 0,16% | Actions |
| Glenview Trust Co | $56 066 | 43 128 | 0,15% | Actions |
| WOLVERINE TRADING, LLC | $52 832 | 25 400 | 0,14% | Option de vente |
| DIMENSIONAL FUND ADVISORS LP | $47 645 | 36 650 | 0,13% | Actions |
| HighTower Advisors, LLC | $45 193 | 34 764 | 0,12% | Actions |
| RHUMBLINE ADVISERS | $39 083 | 30 064 | 0,11% | Actions |
| Point72 Asset Management, L.P. | $36 901 | 28 385 | 0,10% | Actions |
| HSBC HOLDINGS PLC | $36 825 | 28 996 | 0,10% | Actions |
| Quadrature Capital Ltd | $34 927 | 26 867 | 0,10% | Actions |
Activistes et détenteurs de 5%+ 2 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Acorn Bioventures, L.P., Acorn Capital Advisors, GP, LLC, Anders Hove ×2 dépôts | 26 janvier 2023 | · | Dépôt initial | · | SEC |
| Bridger Management, LLC, Roberto Mignone | 5 avril 2016 | · | Dépôt initial | Investissement passif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Initiés de la société 30 initiés · 13 dirigeants · 13 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Mani Mohindru | Chief Executive Officer | 14 juillet 2026 P | 59 067 | 2 | 0 | $80 062 |
| Mark Erlander | Chief Executive Officer | 11 mars 2025 A | 24 481 | 0 | 0 | $0 |
| William J Welch | Chief Executive Officer | 30 janvier 2018 M | 842 645 | 0 | 0 | $0 |
| Joshua B Muntner | Chief Financial Officer | 6 avril 2026 A | · | 0 | 0 | $0 |
| James E. Levine | Chief Financial Officer | 11 mars 2025 A | 67 716 | 0 | 0 | $0 |
| Steve Zaniboni | Former CFO | 21 avril 2016 M | 96 968 | 0 | 0 | $0 |
| Ajay Aggarwal | Chief Operating Officer | 27 avril 2026 A | · | 0 | 0 | $0 |
| Vicki Kelemen | Exec. VP and COO | 15 mars 2023 A | 6 053 | 0 | 0 | $0 |
| Tod Smeal | Chief Scientific Officer | 14 avril 2026 A | · | 0 | 0 | $0 |
| Brigitte Ute Lindsay | Chief Accounting Officer | 13 février 2026 A | · | 0 | 0 | $0 |
| Fairooz Kabbinavar | Chief Medical Officer | 11 mars 2025 A | · | 0 | 0 | $0 |
| Katherine L Ruffner | Chief Medical Officer | 9 mars 2022 A | · | 0 | 0 | $0 |
| Matthew L. Posard | Chief Commercial Officer | 4 janvier 2016 A | · | 0 | 0 | $0 |
| Gary W Pace | Administrateur | 14 juillet 2026 P | 2 043 661 | 2 | 0 | $1 040 036 |
| Lale White | Administrateur | 11 juin 2026 A | 113 788 | 0 | 0 | $0 |
| Renee P Tannenbaum | Administrateur | 11 juin 2026 A | 20 000 | 0 | 0 | $0 |
| Rodney S Markin | Administrateur | 11 juin 2026 A | 23 879 | 0 | 0 | $0 |
| James O Armitage | Administrateur | 11 juin 2026 A | 13 000 | 0 | 0 | $0 |
| Athena Countouriotis | Administrateur | 20 juin 2019 A | · | 0 | 0 | $0 |
| Stanley Tennant | Administrateur | 8 juin 2018 P | 28 839 | 0 | 0 | $0 |
| Paul Billings | Administrateur | 23 janvier 2018 A | 23 165 | 0 | 0 | $0 |
| Carl B Feldbaum | Administrateur | 17 mars 2015 A | · | 0 | 0 | $0 |
| Christopher Mcguigan | Administrateur | 14 février 2013 A | · | 0 | 0 | $0 |
| Robert Merrill Hunter | Détenteur de 10% | 13 avril 2012 P | 5 065 004 | 0 | 0 | $0 |
| John P Brancaccio | · | 9 juin 2022 J | 12 260 | 0 | 0 | $0 |
| Gary S Jacob | · | 10 juin 2021 J | 21 922 | 0 | 0 | $0 |
| Thomas Adams PHD | · | 10 juin 2021 J | 18 875 | 0 | 0 | $0 |
| Antonius Schuh | · | 4 janvier 2016 A | 20 000 | 0 | 0 | $0 |
| Gabriel Cerrone | · | 26 juillet 2013 A | 719 526 | 0 | 0 | $0 |
| Kira Sheinerman | · | 13 août 2008 P | 909 090 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Détention d'ETF Détenu par 4 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
CRDF Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
notation · 12 analystes
ACHAT
Objectif médian
$6.00
+435,7%
2 16,7%
Achat fort
5 41,7%
Achat
5 41,7%
Conserver
0 0,0%
Vente
0 0,0%
Vente forte
Objectif de cours à 12 mois
7 analystes · 2026-10-01Objectif moyen $5.81 +419,1%
← En dessous de tous les objectifs
Prix actuel $1.12
Bas$1.20
Moyenne$5.81
Haut$12.00
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
Base F.A., prix à la clôture de la dernière fin d'exercice de chaque société.
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| CRDF | $192M | -4.1 | -13.2% | -7732.0% | -88.2% | · |
| BMEA | $90M | -1.1 | -67.1% | -3326.0% | -216.6% | · |
| CNXU | · | · | · | · | · | · |
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | · |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | · |
| EQ | $95M | -4.0 | 13.9% | · | -133.1% | · |
| MNOV | $64M | -5.5 | · | -2928.8% | -27.1% | · |
| ICCC | · | -51.2 | 4.3% | · | · | · |
| ACRV | $76M | -1.2 | · | · | -61.0% | · |
| SERA | · | -4.4 | 5.2% | -39417.3% | -39.0% | · |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
Choisissez les indicateurs qui vous importent — cliquez sur le + à côté de n'importe quelle ligne dans les Fondamentaux complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Source : Dépôt SEC 10-Q le Aoû 11, 2026